Overview
Visterra is focused on the discovery and development of innovative products that will transform the prevention and treatment of infectious diseases. Visterra’s groundbreaking technology platform, built around its unique structural understanding of how a virus docks to receptor cell surface glycans (complex sugars), enables the company to rationally design more effective therapeutics and vaccines. The company has established proof of concept with its lead therapeutic product candidate for influenza.